Microbiologics notes that OECD Guideline 497 fixes the data interpretation procedure across in chemico, in vitro and in silico inputs.
Public source
Publisher name
Public post
Where are NAMs actually making go/no-go decisions today? Not in the arena the debate assumes. The public argument is about organ chips and organoids replacing animal stu…
Company
Microbiologics
The world's go-to partners for infectious disease biomaterials and testing services.
- Industry
- Biotechnology Research
- Location
- Saint Cloud, US
- Company size
- 201–500 employees
About Microbiologics
We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
ScitoVation
ScitoVation published a new issue of ScitoVation Insight exploring the FDA's approach to New Approach Methodologies (NAMs) and what sponsors need to know.
Research & Knowledge
CN Bio
CN Bio published a new technology guide exploring how liver microphysiological systems can help researchers generate human-relevant insight, improve translational relevance, and reduce uncertainty in modern toxicology workflows.
Research & Knowledge
Microbial Discovery Group
Microbial Discovery Group conducted chemical analyses of 113 personal care and cleaning products across 12 categories using high-resolution GC × GC-MS with machine-learning-assisted identification to detect 3,141 unique chemicals, including 303 with confirmed, probable, or tentative identification.
Research & Knowledge
MatTek Life Sciences
MatTek Life Sciences published an article in Microtissue Matters by Alex Armento discussing NAMs adoption and its impact on R&D.
Research & Knowledge
VivoSim Labs, Inc.